Global interim guidance on coronavirus disease 2019 (COVID‐19) during pregnancy and puerperium from FIGO and allied partners: Information for healthcare professionals
Liona C. Poon(Chinese University of Hong Kong), Moshe Hod(Tel Aviv University)
Cited by 313
Related Papers
Continuous glucose monitoring in pregnant women with type 1 diabetes (CONCEPTT): a multicentre international randomised controlled trial
|The Lancet|2017|775
The International Federation of Gynecology and Obstetrics (FIGO) Initiative on gestational diabetes mellitus: A pragmatic guide for diagnosis, management, and care<sup>#</sup>
|International Journal of Gynecology & Obstetrics|2015|774
FIGO (International Federation of Gynecology and Obstetrics) initiative on fetal growth: Best practice advice for screening, diagnosis, and management of fetal growth restriction
|International Journal of Gynecology & Obstetrics|2021|534
Multicenter screening for pre‐eclampsia by maternal factors and biomarkers at 11–13 weeks' gestation: comparison with <scp>NICE</scp> guidelines and <scp>ACOG</scp> recommendations
|Ultrasound in Obstetrics and Gynecology|2017|363
Fetal and perinatal outcomes in type 1 diabetes pregnancy: a randomized study comparing insulin aspart with human insulin in 322 subjects
|American Journal of Obstetrics and Gynecology|2007|174